A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
/in Dendritic Cells, Glioblastoma, International Publications /von 2017-05-12 / J Transl Med 2017 05;15(1):104Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation
/in Cervical Cancer, Hyperthermia, International Publications /von 2017-05-04 / Oncol Lett 2017 Jul;14(1):73-78Phase I Trial of Intratumoral Injection of Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 T-cell Infiltration
/in Dendritic Cells, International Publications, NSCLC /von 2017-05-03 / Clin. Cancer Res. 2017 Aug;23(16):4556-4568Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells
/in Acute Leukemia, Hyperthermia, International Publications /von 2017-04-28 / J. Therm. Biol. 2017 Jul;67:9-14A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer
/in Cervical Cancer, Hyperthermia, International Publications /von 2017-04-27 / Radiat Oncol 2017 Apr;12(1):75Temperature measurements in a capacitive system of deep loco-regional hyperthermia
/in Hyperthermia, International Publications /von 2017-04-27 / Electromagn Biol Med 2017;36(3):248-258Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2017-04-27 / Sci Rep 2017 04;7(1):1217Dendritic cell based vaccination strategy: an evolving paradigm
/in Dendritic Cells, Glioblastoma, International Publications /von 2017-04-22 / J. Neurooncol. 2017 Jun;133(2):223-235Treatment outcomes of concurrent hyperthermia and chemoradiotherapy for pancreatic cancer: Insights into the significance of hyperthermia treatment
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2017-04-21 / Oncol Lett 2017 Jun;13(6):4959-4964IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de